Factors That Influence Clinician Prescribing of Corticosteroids for Acute Idiopathic and Multiple Sclerosis–Associated Optic Neuritis: A Qualitative Study

Knowledge of risk/benefits of corticosteroids are necessary but not sufficient for evidence-based I/MS-ON practice. Variation in how clinicians treat patients with acute I/MS-ON is influenced largely by psychosocial factors, such as beliefs about corticosteroid risk/benefit trade-offs and the role of the clinician to provide treatment. Interventions to support evidence-based decision making for I/MS-ON treatment will need to provide risk/benefit information to support clinicians with varying levels of expertise, incorporate patient preference, and normalize the option to observe.

Authors

Institutions

Publication Details

Journal
Journal of Neuro-Ophthalmology
Published
2024-08-16
DOI
https://doi.org/10.1097/wno.0000000000002219
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors That Influence Clinician Prescribing of Corticosteroids for Acute Idiopathic and Multiple Sclerosis–Associated Optic Neuritis: A Qualitative Study

Kevin A. Kerber, Lindsey B. De Lott, Timothy C. Guetterman, Brian J. Zikmund‐Fisher et al.
Journal of Neuro-Ophthalmology
Multiple Sclerosis Research Studies
article

Factors That Influence Clinician Prescribing of Corticosteroids for Acute Idiopathic and Multiple Sclerosis–Associated Optic Neuritis: A Qualitative Study

Kevin A. Kerber, Lindsey B. De Lott, Timothy C. Guetterman, Brian J. Zikmund‐Fisher, Lizbeth A. Gonzalez
article en

Abstract

Knowledge of risk/benefits of corticosteroids are necessary but not sufficient for evidence-based I/MS-ON practice. Variation in how clinicians treat patients with acute I/MS-ON is influenced largely by psychosocial factors, such as beliefs about corticosteroid risk/benefit trade-offs and the role of the clinician to provide treatment. Interventions to support evidence-based decision making for I/MS-ON treatment will need to provide risk/benefit information to support clinicians with varying levels of expertise, incorporate patient preference, and normalize the option to observe.

Journal of Neuro-OphthalmologyVol. 45(2)
The Ohio State University (US)
Research to Prevent Blindness, National Eye Institute
Peace, Justice and strong institutions
Openalex Percentile: Top 79%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.